Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation

Introduction The outcomes related to different anticoagulation doses in Coronavirus disease 2019 (COVID-19) patients are not well established. COVID-19 is associated with increased thrombotic events and early coagulopathy as reported by a large New York City health system. Initial studies on patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kodama, Rich, Kalsi, Amardeep, Singh, Angelica, Vishnuvardhan, Nivetha, Nimkar, Neil, Paul, Sonal, Usta, Soeb, Ashraf, Farah, Mazloom, Anita, Ashfaq, Abeer, Patel, Nisha, Kumarasinghe, Chathula, Khan, Uqba, Gregos, Peter, Weingarten, Jeremy, Patel, Eshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
332.Anticoagulation and Antithrombotic Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330337/
http://dx.doi.org/10.1182/blood-2020-142552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330337/
http://dx.doi.org/10.1182/blood-2020-142552

Ejemplares similares